Deborah Cote Email & Phone Number

Olathe, KS, US

• Launched a new product for host immune response at MeMed and Diasorin, transitioning to a bigger platform at Diasorin with a diverse assay portfolio.
• Excelled in learning new products, finishing 4th out of 28 reps in 2023 and on track for another top 5 in 2024.
• Took a 6-month hiatus to care for family, showcasing dedication to work-life balance.

Salt Lake City, Utah, US

• Designed financial cost benefit models for the Blood culture assay
• Achieved number one rep in revenue growth every year since inception
• Closed an average 95% of all customer evaluations
• Promoted to senior account manager in the Central Region in 2015

• Led sales efforts in the Midwest region for Luminex, focusing on molecular technology adoption in labs.
• Developed financial templates to assist lab managers in justifying the implementation of innovative technology.
• Achieved a top 10 ranking with 5 successful in-house technology placements in the first half of 2019.

• Managed a team of specialists to grow a $6 million base by strategically positioning the BD Diagnostic portfolio in Kansas, Nebraska, and Missouri.
• Developed cost benefit models to expedite sales processes and justify capital equipment sales for various product lines.
• Successfully led initiatives to find support outside the lab and drive persistence in achieving sales targets.

• Managed sales territory covering Missouri, Kansas, Nebraska, and Arkansas for Coagulation products at Dade (Siemens).
• Responsible for maintaining dominant market share, identifying new test opportunities, and completing competitive conversions.
• Achieved sales goals consistently each year, showcasing strong sales acumen and strategic planning skills.

• Successfully introduced and marketed the Fetal Fibronectin (FFN) test to the market, resulting in 50 instrument placements and revenues exceeding a million dollars within 2 years.
• Generated interest at the physician level to drive demand for the lab, effectively justifying the financial investment in the expensive assay.
• Achieved the first highest and second highest placements back-to-back years, earning the prestigious Presidents Club recognition.

I sold Molecular sexually transmitted diseases tests to Hospitals in the Greater Chicago area. Over achieved yearly sales goals in a very competitive market. My technical background helped to communicate the value of molecular over traditional testing methods.